Founders Capital Management - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Founders Capital Management ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$10.0%5,0000.0%0.00%0.0%
Q4 2022$1
-100.0%
5,000
-72.2%
0.00%
-66.7%
Q3 2022$4,000
-55.6%
18,0000.0%0.00%
-57.1%
Q2 2022$9,000
-18.2%
18,0000.0%0.01%0.0%
Q1 2022$11,0000.0%18,0000.0%0.01%0.0%
Q4 2021$11,000
-35.3%
18,0000.0%0.01%
-41.7%
Q3 2021$17,000
-15.0%
18,0000.0%0.01%
-7.7%
Q2 2021$20,000
+150.0%
18,000
+125.0%
0.01%
+116.7%
Q1 2021$8,000
+100.0%
8,0000.0%0.01%
+100.0%
Q4 2020$4,000
+33.3%
8,0000.0%0.00%0.0%
Q1 2020$3,000
-50.0%
8,0000.0%0.00%
-40.0%
Q4 2019$6,000
+100.0%
8,000
+100.0%
0.01%
+150.0%
Q3 2019$3,0000.0%4,000
+100.0%
0.00%
-33.3%
Q2 2019$3,000
-25.0%
2,0000.0%0.00%
-25.0%
Q1 2019$4,000
-20.0%
2,0000.0%0.00%
-20.0%
Q4 2018$5,000
-28.6%
2,0000.0%0.01%
-16.7%
Q3 2018$7,0002,0000.01%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
GROW Partners, LLC 325,000$2,077,0001.27%
DAFNA Capital Management LLC 125,000$799,0000.82%
BARD ASSOCIATES INC 170,925$1,094,0000.46%
MARXE AUSTIN W & GREENHOUSE DAVID M 525,000$3,355,0000.36%
SOPHROSYNE CAPITAL LLC 42,000$267,0000.23%
Granite Point Capital Management, L.P. 205,000$1,310,0000.22%
SABBY MANAGEMENT, LLC 407,024$2,601,0000.17%
SCOGGIN MANAGEMENT LP 150,000$959,0000.08%
Geduld E E 25,000$160,0000.08%
PRELUDE CAPITAL MANAGEMENT, LLC 45,000$288,0000.05%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders